Literature DB >> 23331927

Systematic review and meta-analysis of histopathological factors influencing the risk of lymph node metastasis in early colorectal cancer.

C Beaton1, C P Twine, G L Williams, A G Radcliffe.   

Abstract

AIM: Lymph node (LN) metastases are present in up to 17% of early colorectal cancers (pT1). Identification of associated histopathological factors would enable counselling of patients regarding this risk.
METHOD: Pubmed and Embase were employed utilizing the terms 'early colorectal cancer', 'lymph node metastasis', 'submucosal invasion', 'lymphovascular invasion', 'tumour budding' and 'histological differentiation'. Analysis was performed using REVIEW MANAGER 5.1.
RESULTS: Twenty-three cohort studies including 4510 patients were analysed. There was a significantly higher risk of LN metastasis with a depth of submucosal invasion > 1 mm than with lesser degrees of penetration (OR 3.87, 95% CI 1.50-10.00, P = 0.005). Lymphovascular invasion was significantly associated with LN metastasis (OR 4.81, 95% CI 3.14-7.37, P < 0.00001). Poorly differentiated tumours had a higher risk of LN metastasis compared with well or moderately differentiated tumours (OR 5.60, 95% CI 2.90-10.82, P < 0.00001). Tumour budding was found to be significantly associated with LN metastasis (OR 7.74, 95% CI 4.47-13.39, P < 0.001).
CONCLUSION: Meta-analysis of the current literature demonstrates that in early colorectal cancer a depth of submucosal invasion by the primary tumour of > 1 mm, lymphovascular invasion, poor differentiation and tumour budding are significantly associated with LN metastasis.
© 2013 The Authors. Colorectal Disease © 2013 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Early colorectal cancer; histological differentiation; lymph node metastasis; lymphovascular invasion; submucosal invasion; tumour budding

Mesh:

Year:  2013        PMID: 23331927     DOI: 10.1111/codi.12129

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  64 in total

1.  Practice parameters for early colon cancer management: Italian Society of Colorectal Surgery (Società Italiana di Chirurgia Colo-Rettale; SICCR) guidelines.

Authors:  F Bianco; A Arezzo; F Agresta; C Coco; R Faletti; Z Krivocapic; G Rotondano; G A Santoro; N Vettoretto; S De Franciscis; A Belli; G M Romano
Journal:  Tech Coloproctol       Date:  2015-09-24       Impact factor: 3.781

Review 2.  Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer.

Authors:  Hiroo Wada; Manabu Shiozawa; Kayoko Katayama; Naoyuki Okamoto; Yohei Miyagi; Yasushi Rino; Munetaka Masuda; Makoto Akaike
Journal:  J Gastroenterol       Date:  2015-03-01       Impact factor: 7.527

3.  Tumour budding predicts increased recurrence after curative resection for T2N0 colorectal cancer

Authors:  Richard Garfinkle; Lawrence Lee; Marylise Boutros; Marie-Josee Cardin; Alan Spatz; Nancy Morin
Journal:  Can J Surg       Date:  2019-10-01       Impact factor: 2.089

4.  Double immunohistochemistry enhances detection of lymphatic and venous invasion in early-stage colorectal cancer.

Authors:  A J Ervine; H A McBride; P J Kelly; M B Loughrey
Journal:  Virchows Arch       Date:  2015-06-16       Impact factor: 4.064

5.  A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study.

Authors:  Hiroshi Kawachi; Yoshinobu Eishi; Hideki Ueno; Tetsuo Nemoto; Takahiro Fujimori; Akinori Iwashita; Yoichi Ajioka; Atsushi Ochiai; Shingo Ishiguro; Tadakazu Shimoda; Hidetaka Mochizuki; Yo Kato; Hidenobu Watanabe; Morio Koike; Kenichi Sugihara
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

6.  Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions.

Authors:  Chihiro Yasue; Akiko Chino; Manabu Takamatsu; Ken Namikawa; Daisuke Ide; Shoichi Saito; Masahiro Igarashi; Junko Fujisaki
Journal:  J Gastroenterol       Date:  2019-02-27       Impact factor: 7.527

7.  T1 colon cancer in the era of screening: risk factors and treatment.

Authors:  F Bianco; S De Franciscis; A Belli; A Falato; R Fusco; D F Altomare; A Amato; C R Asteria; A Avallone; G A Binda; L Boccia; P Buzzo; M Carvello; C Coco; P Delrio; P De Nardi; M Di Lena; A Failla; F La Torre; M La Torre; M Lemma; P Luffarelli; G Manca; I Maretto; F Marino; A Muratore; A Pascariello; S Pucciarelli; D Rega; V Ripetti; G Rizzo; A Serventi; A Spinelli; F Tatangelo; E D L Urso; G M Romano
Journal:  Tech Coloproctol       Date:  2017-02-13       Impact factor: 3.781

8.  Variability in management of T1 colorectal cancer in Wales.

Authors:  U Khalid; M D Evans; G L Williams; J Hanson; M Davies
Journal:  Ann R Coll Surg Engl       Date:  2013-10       Impact factor: 1.891

9.  Poorly differentiated clusters (PDCs) as a novel histological predictor of nodal metastases in pT1 colorectal cancer.

Authors:  Valeria Barresi; Giovanni Branca; Antonio Ieni; Luca Reggiani Bonetti; Luigi Baron; Stefania Mondello; Giovanni Tuccari
Journal:  Virchows Arch       Date:  2014-04-27       Impact factor: 4.064

10.  Interobserver variability amongst gastrointestinal pathologists in assessing prognostic parameters of malignant colorectal polyps: a cause for concern.

Authors:  A Davenport; J Morris; S A Pritchard; E Salmo; M Scott; N Y Haboubi
Journal:  Tech Coloproctol       Date:  2016-08-13       Impact factor: 3.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.